Clopidogrel and cardiac surgery: Enemy or friend?

Heart

Volumn 98, Issue 23, 2012, Pages 1685-1686

  Elefteriades, John A ^a   Meier, Pascal ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; EDITORIAL; GRAFT FAILURE; GRAFT OCCLUSION; HEART DEATH; HEART INFARCTION; HEART SURGERY; HUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK REDUCTION; THROMBOSIS; VASCULAR PATENCY; VEIN GRAFT;

ACUTE CORONARY SYNDROME; ASPIRIN; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY OCCLUSION; FEMALE; HUMANS; MALE; PLATELET AGGREGATION; TICLOPIDINE;

EID: 84869180322     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302822     Document Type: Editorial

References (13)

1. Berger JS, Frye CB, Harshaw Q, et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. J Am Coll Cardiol 2008;52:1693-701.
2. Sabik JF III. Understanding saphenous vein graft patency. Circulation 2011;124:273-5.
3. Mannacio V, Di Tommaso L, et al. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomized study. Heart 2012;981709-14. doi:10.1136/heartjnl-2012- 302449.
4. Khot UN, Friedman DT, Pettersson G, et al. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary art1ries and saphenous vein grafts. Circulation 2004;109:2086-91.
5. Ibrahim K, Tjomsland O, Halvorsen D, et al. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery. Heart Surg Forum 2006;9:E5818-56.
6. Kulik A, Le May MR, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circulation 2010;122:2680-7.
7. Sorensen R, Abildstrom SZ, Hansen PR, et al. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction. J Am Coll Cardiol 2011;57:1202-9.
8. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
9. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:e123-210.
10. Stein PD, Schunemann HJ, Dalen JE, et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:600S-8S.
11. Taggart DP, Boyle R, de, et al. The 2010 ESC/EACTS guidelines on myocardial revascularisation. Heart 2011;97:445-6.
12. Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110:1202-8.
13. Halabi AR, Alexander JH, Shaw LK, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 2005;96:1254-9.